Liberum Capital reiterated their buy rating on shares of Galliford Try (LON:GFRD) in a research report released on Wednesday, ThisIsMoney.Co.Uk reports.
Several other equities analysts have also commented on GFRD. Peel Hunt reiterated an under review rating on shares of Motif Bio in a research report on Monday, July 15th. Canaccord Genuity reiterated a hold rating and set a GBX 860 ($11.24) price objective on shares of Galliford Try in a research report on Tuesday, May 21st. Finally, Numis Securities reiterated a hold rating and set a GBX 1,618 ($21.14) price objective on shares of Close Brothers Group in a research report on Wednesday, May 22nd. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Galliford Try currently has a consensus rating of Hold and a consensus price target of GBX 868 ($11.34).
GFRD stock opened at GBX 642 ($8.39) on Wednesday. Galliford Try has a 52 week low of GBX 499.60 ($6.53) and a 52 week high of GBX 1,117 ($14.60). The company has a quick ratio of 0.80, a current ratio of 1.21 and a debt-to-equity ratio of 159.63. The company’s fifty day simple moving average is GBX 632.95. The company has a market capitalization of $712.83 million and a price-to-earnings ratio of 6.23.
Galliford Try plc operates as a housebuilding, regeneration, and construction primarily in the United Kingdom. The company operates through Linden Homes, Partnerships & Regeneration, Building, Infrastructure, and PPP Investments segments. The company develops and sells private and affordable homes under the Linden Homes brand name; and builds sustainable communities, as well as provides private housing for sale on regeneration-led sites.
See Also: Net Income
Receive News & Ratings for Galliford Try Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galliford Try and related companies with MarketBeat.com's FREE daily email newsletter.